These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 1318677)

  • 41. Azithromycin-induced block of elementary body formation in Chlamydia trachomatis.
    Engel JN
    Antimicrob Agents Chemother; 1992 Oct; 36(10):2304-9. PubMed ID: 1280057
    [TBL] [Abstract][Full Text] [Related]  

  • 42. In vitro activity of the two new 4-quinolones A56619 and A56620 against Neisseria gonorrhoeae, Chlamydia trachomatis, Mycoplasma hominis, Ureaplasma urealyticum and Gardnerella vaginalis.
    Tjiam KH; Wagenvoort JH; van Klingeren B; Piot P; Stolz E; Michel MF
    Eur J Clin Microbiol; 1986 Oct; 5(5):498-501. PubMed ID: 3096726
    [TBL] [Abstract][Full Text] [Related]  

  • 43. In vitro activity of a new ketolide antibiotic, HMR 3647, against Chlamydia pneumoniae.
    Roblin PM; Hammerschlag MR
    Antimicrob Agents Chemother; 1998 Jun; 42(6):1515-6. PubMed ID: 9624507
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Pharmacokinetics of azithromycin and erythromycin in human endometrial epithelial cells and in cells infected with Chlamydia trachomatis.
    Raulston JE
    J Antimicrob Chemother; 1994 Nov; 34(5):765-76. PubMed ID: 7706172
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Comparative study of minimal inhibiting concentrations of doxycycline, ofloxacin and erythromycin against 18 recent isolates from Chlamydia trachomatis (1994-1995)].
    Bianchi A; Legouge R; Lefevre JC; Askienazy-Elbhar M; Joly-Guillou ML; Pavis A; Sednaoui P
    Pathol Biol (Paris); 1996 May; 44(5):347-50. PubMed ID: 8758473
    [TBL] [Abstract][Full Text] [Related]  

  • 46. High treatment failure rate is better explained by resistance gene detection than by minimum inhibitory concentration in patients with urogenital Chlamydia trachomatis infection.
    Shao L; You C; Cao J; Jiang Y; Liu Y; Liu Q
    Int J Infect Dis; 2020 Jul; 96():121-127. PubMed ID: 32173573
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Cost-effectiveness analysis of five different antibiotic regimens for the treatment of uncomplicated Chlamydia trachomatis cervicitis.
    Nuovo J; Melnikow J; Paliescheskey M; King J; Mowers R
    J Am Board Fam Pract; 1995; 8(1):7-16. PubMed ID: 7701965
    [TBL] [Abstract][Full Text] [Related]  

  • 48. In vitro susceptibilities of Mycoplasma pneumoniae, Mycoplasma hominis, and Ureaplasma urealyticum to sparfloxacin and PD 127391.
    Waites KB; Duffy LB; Schmid T; Crabb D; Pate MS; Cassell GH
    Antimicrob Agents Chemother; 1991 Jun; 35(6):1181-5. PubMed ID: 1929260
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Methodologies and cell lines used for antimicrobial susceptibility testing of Chlamydia spp.
    Suchland RJ; Geisler WM; Stamm WE
    Antimicrob Agents Chemother; 2003 Feb; 47(2):636-42. PubMed ID: 12543671
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Efficacy of single-dose azithromycin versus doxycycline in the treatment of cervical infections caused by Chlamydia trachomatis.
    Ossewaarde JM; Plantema FH; Rieffe M; Nawrocki RP; de Vries A; van Loon AM
    Eur J Clin Microbiol Infect Dis; 1992 Aug; 11(8):693-7. PubMed ID: 1330565
    [TBL] [Abstract][Full Text] [Related]  

  • 51. In-vitro activity of dirithromycin against Chlamydia pneumoniae.
    Roblin PM; Kutlin A; Sokolovskaya N; Hammerschlag MR
    J Antimicrob Chemother; 1997 May; 39(5):647-9. PubMed ID: 9184366
    [TBL] [Abstract][Full Text] [Related]  

  • 52. In vitro susceptibilities of Chlamydia pneumoniae (Chlamydia sp. strain TWAR).
    Chirgwin K; Roblin PM; Hammerschlag MR
    Antimicrob Agents Chemother; 1989 Sep; 33(9):1634-5. PubMed ID: 2817862
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Chlamydia trachomatis clinical isolates identified as tetracycline resistant do not exhibit resistance in vitro: whole-genome sequencing reveals a mutation in porB but no evidence for tetracycline resistance genes.
    O'Neill CE; Seth-Smith HMB; Van Der Pol B; Harris SR; Thomson NR; Cutcliffe LT; Clarke IN
    Microbiology (Reading); 2013 Apr; 159(Pt 4):748-756. PubMed ID: 23378575
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Randomised controlled trial of single-dose azithromycin in treatment of trachoma.
    Bailey RL; Arullendran P; Whittle HC; Mabey DC
    Lancet; 1993 Aug; 342(8869):453-6. PubMed ID: 8102427
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [In vitro inhibition of Chlamydia trachomatis growth by liposome-encapsulated cyclines].
    Sangaré L; Morisset R; Ravaoarinoro M
    Pathol Biol (Paris); 2001 Feb; 49(1):53-6. PubMed ID: 11265224
    [TBL] [Abstract][Full Text] [Related]  

  • 56. In vitro activity of nemonoxacin, a novel nonfluorinated quinolone antibiotic, against Chlamydia trachomatis and Chlamydia pneumoniae.
    Chotikanatis K; Kohlhoff SA; Hammerschlag MR
    Antimicrob Agents Chemother; 2014; 58(3):1800-1. PubMed ID: 24366753
    [TBL] [Abstract][Full Text] [Related]  

  • 57. In vitro activities of rifamycin derivatives ABI-1648 (Rifalazil, KRM-1648), ABI-1657, and ABI-1131 against Chlamydia trachomatis and recent clinical isolates of Chlamydia pneumoniae.
    Roblin PM; Reznik T; Kutlin A; Hammerschlag MR
    Antimicrob Agents Chemother; 2003 Mar; 47(3):1135-6. PubMed ID: 12604555
    [TBL] [Abstract][Full Text] [Related]  

  • 58. New treatments for Chlamydia trachomatis.
    Jones RB
    Am J Obstet Gynecol; 1991 Jun; 164(6 Pt 2):1789-93. PubMed ID: 2039033
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Suboptimal efficacy of erythromycin and tetracycline against vaginal Ureaplasma urealyticum.
    Bowie WR; Willetts V
    Sex Transm Dis; 1987; 14(2):88-91. PubMed ID: 3112969
    [TBL] [Abstract][Full Text] [Related]  

  • 60. In vitro susceptibilities of 176 clinical isolates of Streptococcus pneumoniae to 11 beta-lactams, erythromycin, and tetracycline.
    Vanhoof R; Carpentier M; Glupczynski Y; Gordts B; Magerman K; Nyssen HJ; Simon A; Surmont I; Van de Vyvere M; Van Landuyt H; Van Nimmen L; Van Noyen R
    Acta Clin Belg; 1996; 51(6):377-85. PubMed ID: 8997755
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.